Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | EVP, Life & Health | February 01, 2022 | February 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date February 01, 2022 · Filed February 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $52.70 · Expires 2032-02-01 | Direct | 47,439 |
Reported balance
After 2022-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-02-01 · Grant · Acquired 47,439 · Balance 47,439 F1: Option to buy stock with tandem stock appreciation right. F2: Option shares vest in three equal consecutive annual installments beginning on February 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Option to buy stock with tandem stock appreciation right.
F2: Option shares vest in three equal consecutive annual installments beginning on February 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2022 Filed Feb 3, 2022 17:38 UTC | KEMPER Corp KMPR · Entity 719 | GrantEmployee Stock Option · Derivative | 47,439 | $0.00 Strike: $52.70 | $0.00 |
DisclosureSEC source: 0000860748-22-000029 · wf-form4_164390992451750.xml · derivative · entry 1 Sternberg Erich · CIK 0001807635 · EVP, Life & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,439 Underlying: Common Stock · 47,439 shares Expires 2032-02-01 F1 · security: Option to buy stock with tandem stock appreciation right. F2 · derivative.exercise_date: Option shares vest in three equal consecutive annual installments beginning on February 1, 2023. Read SEC document |
| February 02, 2021 Filed Feb 5, 2021 01:17 UTC | KEMPER Corp KMPR · Entity 719 | GrantEmployee Stock Option · Derivative | 12,906 | $0.00 Strike: $69.74 | $0.00 |
DisclosureSEC source: 0000860748-21-000027 · wf-form4_161248780381990.xml · derivative · entry 1 Sternberg Erich · CIK 0001807635 · EVP, Life & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,906 Underlying: Common Stock · 12,906 shares Expires 2031-02-02 F1 · security: Option to buy stock with tandem stock appreciation right. F2 · derivative.exercise_date: Option shares vest in three equal consecutive annual installments beginning on 2/2/2022. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:00 UTC | KEMPER Corp KMPR · Entity 719 | GrantEmployee Stock Option · Derivative | 40,623 | $0.00 Strike: $71.39 | $0.00 |
DisclosureSEC source: 0000860748-20-000061 · wf-form4_158586119571700.xml · derivative · entry 1 Sternberg Erich · CIK 0001807635 · EVP, Life & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,623 Underlying: Common Stock · 40,623 shares Expires 2030-04-01 F1 · security: Option to buy stock with tandem stock appreciation right. F2 · derivative.exercise_date: Option shares vest in three equal consecutive annual installments beginning on 4/1/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.